Biotalys Notice of Half Year 2021 Results

24 Aug 2021
www.globenewswire.com
Ghent, BELGIUM , Aug. 24, 2021 (GLOBE NEWSWIRE) -- Press release Biotalys Notice of Half Year 2021 Results Ghent, BELGIUM – 24 August 2021 – Biotalys NV (Euronext Brussels: BTLS), an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for a more sustainable and safer food supply, announces today that it will publish its consolidated results for the first half of 2021 on Friday, 17 September 2021 at 07:00 CEST. Webcast and Conference Call InformationIn addition to the publication of its results, Patrice Sellès, Chief Executive Officer, and Wim Ottevaere, Chief Financial Officer, will host a webcast and conference call followed by a Q&A session, conducted in English. The webcast will be held on Friday, 17 September 2021 at 15:00 CEST / 14:00 BST / 09:00 EDT and can be accessed via the following link on the Biotalys investor website: . A recording of the webcast will be available after the event on the Biotalys' investor website: . - ENDS - For further information, please contact: BiotalysToon Musschoot, Head of IR and CommunicationsT: +32 (0)9 274 54 00E: Toon.Musschoot@biotalys.com For media enquiries, please contact:Consilium Strategic CommunicationsAmber FennellT: +44 (0)203 709 5700E: Biotalys@consilium-comms.com About Biotalys Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for more sustainable and safer food. Based on its novel AGROBODY™ technology platform, Biotalys aims to develop a strong and diverse pipeline of effective products with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and was listed on Euronext Brussels in July 2021. The Company is based in the biotech cluster in Ghent, Belgium. More information can be found on .
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.